The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer

Clinical trial NCT00440128 · COMPLETED

Trial details

NCT number: NCT00440128
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Nausea and Vomiting, Chemotherapy-Induced

Start date: 2007-05-04
Primary completion: 2008-07-17
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.